Saeid Fard-Najafi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Type 2 Diabetes Reshapes the B-Cell Compartment in Tuberculosis, with Reduction of Transitional B Cells and Expansion of Plasmablasts.

Type 2 Diabetes Reshapes the B-Cell Compartment in Tuberculosis, with Reduction of Transitional B Cells and Expansion of Plasmablasts.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 27, 2026

Impact of diabetes on TB infection diagnosis.

Impact of diabetes on TB infection diagnosis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 16, 2026

Stage-Specific Immune Responses to AgB T-Peptides in Patients with Cystic Echinococcosis.

Stage-Specific Immune Responses to AgB T-Peptides in Patients with Cystic Echinococcosis.

Journal: Infectious disease reports
Published: March 10, 2025

Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis.

Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis.

Journal: Frontiers in immunology
Published: April 03, 2024

Evaluation of the Local and Peripheral Immune Responses in Patients with Cystic Echinococcosis.

Evaluation of the Local and Peripheral Immune Responses in Patients with Cystic Echinococcosis.

Journal: Pathogens (Basel, Switzerland)
Published: March 25, 2024

Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases.

Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases.

Journal: Frontiers in medicine
Published: August 02, 2023

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences.

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences.

Journal: Frontiers in immunology
Published: June 22, 2023

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 31, 2023

Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis.

Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis.

Journal: PLoS neglected tropical diseases
Published: October 17, 2022

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.

Journal: Frontiers in immunology
Published: July 01, 2022

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

Journal: Cells
Published: November 18, 2021

Multi-omics approach to COVID-19: a domain-based literature review.

Multi-omics approach to COVID-19: a domain-based literature review.

Journal: Journal of translational medicine
Published: August 25, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026